Psychedelic Stocks Rise Following Trump's Order to Accelerate PTSD Research
Psychedelic-related stocks increased in premarket trading after President Donald Trump signed an executive order to accelerate PTSD research and expand access to certain substances. Compass Pathways and AtaiBeckley were among the top gainers, with Compass Pathways rising 25%.
Topics: executive_order psychedelic_stocks PTSD_treatment stock_trading